指南与共识自身炎症与 IgG4 相关病

慢性非细菌性骨髓炎对非甾体抗炎药无效和/或伴活动性脊柱病变的共识治疗方案

Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions.
指南 / 共识 · Arthritis Care Res (Hoboken) · 2018-07-12

儿童关节炎与风湿病研究联盟(CARRA)的CNO/CRMO亚组通过文献检索、成员调查和名义群体技术达成共识,为对非甾体抗炎药(NSAID)单药治疗无效和/或伴活动性脊柱病变的慢性非细菌性骨髓炎(CNO)患儿制定了3种共识治疗方案(CTPs),并确定了受试者入选标准、初始评估和数据收集项目。

要点

  • 针对NSAID无效和/或活动性脊柱病变的CNO患儿,制定3种为期12个月的CTPs。
  • 3种CTPs分别为甲氨蝶呤或柳氮磺吡啶、肿瘤坏死因子抑制剂(可选联用甲氨蝶呤)、双膦酸盐。
  • 所有方案均允许短期使用糖皮质激素和继续使用NSAIDs。

核心结论

  • 为对NSAIDs无效和/或伴活动性脊柱病变的儿童CNO患者制定了3种共识治疗方案,将提供疗效信息并为比较有效性研究生成有意义的数据。

研究设计与样本

  • 在CARRA的CNO/CRMO亚组内通过虚拟和面对面讨论及会议,结合文献检索和CARRA成员调查,采用名义群体技术达成共识。

主要发现

  • 制定了3种用于CNO患者初始12个月治疗的共识治疗方案(CTPs),适用于对NSAID单药治疗无效和/或伴活动性脊柱病变者。
  • 3种CTPs为甲氨蝶呤或柳氮磺吡啶、肿瘤坏死因子抑制剂(可选联用甲氨蝶呤)、双膦酸盐。
  • 所有方案均允许短期使用糖皮质激素和继续使用NSAIDs。
  • CARRA成员就这些CTPs达成共识,并就受试者入选标准、启动CTPs前应进行的初始评估以及评估治疗反应的数据收集项目达成共识。

关键数值与推荐

  • 3种CTPs适用于对NSAID单药治疗无效和/或伴活动性脊柱病变的CNO患者,治疗期为初始12个月。
  • CTPs包括甲氨蝶呤或柳氮磺吡啶、肿瘤坏死因子抑制剂(可选联用甲氨蝶呤)、双膦酸盐。
  • 所有方案允许短期使用糖皮质激素和继续使用NSAIDs。

临床怎么用

  • 对NSAID单药治疗无效和/或伴活动性脊柱病变的儿童CNO患者,可参考上述3种CTPs选择治疗方案。
  • 启动CTPs前应按照共识进行初始评估,并收集共识确定的数据项目以评估治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop standardized treatment regimens for chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), to enable comparative effectiveness treatment studies. METHODS: Virtual and face-to-face discussions and meetings were held within the CNO/CRMO subgroup of the Childhood Arthritis and Rheumatology Research Alliance (CARRA). A literature search was conducted, and CARRA membership was surveyed to evaluate available treatment data and identify current treatment practices. Nominal group technique was used to achieve consensus on treatment plans for CNO refractory to nonsteroidal antiinflammatory drug (NSAID) monotherapy and/or with active spinal lesions. RESULTS: Three consensus treatment plans (CTPs) were developed for the first 12 months of therapy for CNO patients refractory to NSAID monotherapy and/or with active spinal lesions. The 3 CTPs are methotrexate or sulfasalazine, tumor necrosis factor inhibitors with optional methotrexate, and bisphosphonates. Short courses of glucocorticoids and continuation of NSAIDs are permitted for all regimens. Consensus was achieved on these CTPs among CARRA members. Consensus was also reached on subject eligibility criteria, initial evaluations that should be conducted prior to the initiation of CTPs, and data items to collect to assess treatment response. CONCLUSION: Three consensus treatment plans were developed for pediatric patients with CNO refractory to NSAIDs and/or with active spinal lesions. Use of these CTPs will provide additional information on efficacy and will generate meaningful data for comparative effectiveness research in CNO.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Zhao Y, Wu EY, Oliver MS, et al. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res (Hoboken). 2018. PMID: 29112802. doi:10.1002/acr.23462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。